Columbia Banking System delivered a clean beat on profitability: operating EPS of $0.82 topped the $0.77 consensus by 6.5% and rose for a second straight quarter, from $0.72 in Q1 and $0.76 in Q2. Earnings Whispers' revenue figure of $912.0 million beat consensus by 32.6% and grew 11.6% year over year. That revenue measure includes gross interest income. On the company's own net revenue basis, revenue was $695 million, up 19% from a year ago. Despite the sequential gains, operating EPS still fell 3.5% from the year-ago $0.85. That central tension runs through the quarter: Columbia is getting markedly more profitable per dollar of assets, while the asset base it earns on keeps shrinking.

The quality of the beat is mostly good. Net interest income rose $26 million sequentially to $615 million, and the net interest margin jumped 18 basis points to 4.11%. That crossed management's 4% target. About 3 basis points came from accelerated payoffs of two acquired loans. Q2 had been depressed by 3 basis points of interest reversals, so the underlying margin is closer to 4.08%. That is still a genuine step up. The drivers were structural:

• Loan yields rose to 5.90% from 5.77% as the mix shifted toward relationship lending.
• Securities yields recovered.
• Customer deposits replaced expensive wholesale funding.

Core expenses were essentially flat at $365 million, and merger costs have nearly disappeared. GAAP EPS of $0.78 is now close to operating EPS, a sign the Pacific Premier integration noise has largely cleared. Operating ROTCE climbed to 17.11%, and operating PPNR grew 7% sequentially and 25% year over year.

Beneath the surface, the balance sheet tells a less flattering story. Loans fell again to $46.9 billion, from $47.7 billion in Q1 and $47.2 billion in Q2, and average earning assets slid to $59.8 billion. Non-owner-occupied CRE balances dropped 13% year over year. Management blamed what it called irrational competition, including SOFR+100 pricing and non-recourse structures. Commercial lines and term loans did grow, and the pace of decline slowed. However, management guided loans flat to slightly down through Q1 and does not expect growth until around mid-2027. On the funding side, customer deposits rose nearly $1.2 billion, much of it from commercial clients and legacy Southern California offices. That allowed a $1.5 billion reduction in wholesale funding and a $1 billion cut in borrowings. This is a bank optimizing its balance sheet rather than growing it.

Guidance contains a near-term step back. Management expects the Q4 margin to be about 4.05%, below the 4.11% print. It attributed the decline to carrying excess subordinated debt ahead of roughly $240 million in trust-preferred redemptions and to seasonal deposit outflows. Those redemptions are expected to turn into a modest margin tailwind in 2027, when management sees the margin expanding from the low-4% range. Fee income is guided to the mid-$80 millions after easing to $87 million. Other cautions:

• Provision expense rose to $33 million from $27 million on rate-driven macro assumptions.
• The September Fed hike and assumed further increases were cited as a risk to borrowers and deposit costs.
• Tangible book value fell to $18.10 from $19.22 as AOCI losses on the securities portfolio widened sharply.

Credit itself looked stable, with net charge-offs at 0.24%, non-performing assets down to 0.39%, and early-stage delinquencies falling.

Capital return is the most tangible catalyst. Columbia completed its prior buyback, retiring 7.8% of shares at an average of $29.88. The board authorized a new $1.2 billion program with no expiration, and management signaled a pace of $150 to $200 million per quarter. Potential Basel III capital relief is being treated as upside rather than built into that plan. With shares at $29.20, Columbia is buying at roughly the price it has been paying.

The market was not leaning bullish going in. Investor sentiment swung from slightly positive (0.05) to clearly negative (-0.22), a meaningful deterioration. Shares are down 5.9% since the open after the July report. They sit about 2% below the 200-day moving average, 11% under the August 17 high of $32.83, and 5.6% above the October 14 low. Price and AVWAP trends remain negative, while sequential growth and momentum readings are neutral. That fits a stock where improving returns have not yet offset concerns about a shrinking balance sheet, falling tangible book, and rising rates.

The bottom line is that Columbia's quarter showed real execution: a 4%-plus margin, returns at multi-quarter highs, disciplined costs, and a larger buyback. Bears still have legitimate ammunition. Loans keep contracting, management guides the Q4 margin lower, and tangible book has taken an AOCI hit. Earnings growth now rests on margin and share count rather than on balance sheet expansion. Until loan growth resumes, the market may keep treating the stock as a buyback-supported income story rather than a growth one.